Investing.com — US stock traded higher Tuesday, bouncing after the previous session’s losses ahead of more comments from a series of Fed speakers.
Here are some of the biggest premarket US stock movers today
-
Honeywell (NASDAQ:) stock rose 3% after the Wall Street Journal reported that the conglomerate was planning to spin off its Advanced Materials business.
-
Alphabet (NASDAQ:) stock rose 0.3% despite its Google unit being ordered by a US judge to reconfigure its Android operating system to allow rivals to make their own app marketplaces and payment options, marking a setback for the tech giant’s defense against antitrust claims.
-
PepsiCo (NASDAQ:) stock fell 1.2% after the soft drinks giant reported third-quarter earnings that beat analyst expectations reported third-quarter revenue which fell short of estimates as the company faced subdued category performance in North America and international business disruptions.
-
Super Micro Computer (NASDAQ:) stock rose 3.8%, extending recent gains after the server manufacturer reported a significant increase in graphics processing unit shipments, driven by the growing demand for artificial intelligence capabilities.
-
Alibaba (NYSE:) stock fell 7.9%, JD (NASDAQ:) stock slipped 10% and Bilibili (NASDAQ:) stock slumped 15% with US-listed Chinese companies sliding as optimism over China’s stimulus measures waned.
-
Qualcomm (NASDAQ:) stock fell 1.3% after the chipmaker published a security advisory addressing vulnerabilities found in its product.
-
DocuSign (NASDAQ:) stock rose 5.5% after S&P Dow Jones Indices said that the e-signature company will join the S&P Midcap 400 Index before trading opens Oct. 11.
-
Affirm Holdings (NASDAQ:) stock rose 4.6% after BTIG upgraded its stance on the fintech company to ‘buy’ from ‘neutral’, while American Express (NYSE:) stock fell 0.7% as BTIG cut it to ‘sell’ from ‘neutral’.
-
Otis Worldwide (NYSE:) stock fell 3.5% after Wolfe Research downgraded its stance on the elevator manufacturer to ‘peer perform’ from ‘outperform’, saying risk/reward is back in balance after recent gains on Chinese stimulus measures.
-
Sage Therapeutics (NASDAQ:) stock fell 13% after the biopharmaceutical announced disappointing topline results from its potential drug to treat mild cognitive impairment and mild dementia due to Alzheimer’s disease.
Read the full article here
